Download Cinnamaldehyde: a new treatment of benign prostatic hyperplasia

Cinnamaldehyde: a new treatment of benign prostatic hyperplasia
medicine
Benign prostatic hyperplasia (BPH) is the area around the urethra, the prostate
cells, benign adenomatous hyperplasia, studies have shown that patients with the body
of a substance known as DHT is the main incentive for BPH. In older men, BPH is a
common disease, clinical statistics show during 40 to 79 years old , benign prostatic
hyperplasia incidence about 50%, the incidence for the men over 80 years old is
80%. BPH is not only seriously affected the quality of life of patients, but also likely
to cause a variety of potential complications: such as acute urinary retention, urinary
tract infections, gross hematuria, bladder diverticula, stones, hydronephrosis, renal
failure.
Currently, the clinical treatment of benign prostatic hyperplasia is the main
methods used to wait for vigilance, surgery and drug therapy. Because drug treatment
has the advantage of safe, convenient, painless and so on , clinical control and
therefore the best choice for the treatment of BPH. Currently there are drugs for
BPH-blockers, these drugs are exported through the expansion of the bladder and
prostate smooth muscle to relieve symptoms. However, these drugs can reduce
prostate size, is also no information can prevent its long-term complications. There is
a 5α-reductase inhibitors, such drugs on behalf of the product is finasteride, which can
effectively reduce prostate size, but the drug finasteride is a long time, usually after 6
months continuous treatment until cured, this will greatly increase the financial
burden of patients.
For this, medical experts have found that the use of cinnamic aldehyde as the raw
material can be prepared a significant effect of BPH treatments. After further research,
experts say this new drug with the conditions of industrial production, then,
cinnamaldehyde may be able to become a new medicine for the treatment of BPH.